Stratec SE Share Price

Equities

SBS

DE000STRA555

Advanced Medical Equipment & Technology

Market Closed - Xetra 09:08:07 31/05/2024 pm IST 5-day change 1st Jan Change
47.65 EUR +2.14% Intraday chart for Stratec SE +6.24% +4.61%

Financials

Sales 2024 * 27Cr 29Cr 2.41TCr Sales 2025 * 29Cr 31Cr 2.62TCr Capitalization 58Cr 63Cr 5.24TCr
Net income 2024 * 1.6Cr 1.74Cr 144.82Cr Net income 2025 * 2.3Cr 2.5Cr 208.18Cr EV / Sales 2024 * 2.62 x
Net Debt 2024 * 12Cr 13Cr 1.05TCr Net Debt 2025 * 7.96Cr 8.64Cr 720.69Cr EV / Sales 2025 * 2.27 x
P/E ratio 2024 *
35.5 x
P/E ratio 2025 *
24.9 x
Employees 1,473
Yield 2024 *
1.83%
Yield 2025 *
1.91%
Free-Float 59.43%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.14%
1 week+6.24%
1 month+11.20%
3 months+10.56%
6 months+20.48%
Current year+4.61%
More quotes
1 week
45.40
Extreme 45.4
47.65
1 month
40.55
Extreme 40.55
47.65
Current year
36.25
Extreme 36.25
47.65
1 year
36.00
Extreme 36
69.00
3 years
36.00
Extreme 36
147.40
5 years
36.00
Extreme 36
147.40
10 years
34.95
Extreme 34.95
147.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 01/98/01
Director of Finance/CFO 57 01/98/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 58 29/19/29
Chairman 66 20/22/20
Director/Board Member 71 21/20/21
More insiders
Date Price Change Volume
31/24/31 47.65 +2.14% 23,177
30/24/30 46.65 +2.08% 7,201
29/24/29 45.7 -1.40% 6,795
28/24/28 46.35 +0.87% 3,931
27/24/27 45.95 +2.45% 1,796

Delayed Quote Xetra, May 31, 2024 at 09:08 pm IST

More quotes
Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
47.65 EUR
Average target price
42.33 EUR
Spread / Average Target
-11.16%
Consensus

Quarterly revenue - Rate of surprise